2023
DOI: 10.3389/fmed.2023.1289642
|View full text |Cite
|
Sign up to set email alerts
|

Current status and development direction of immunomodulatory therapy for intervertebral disk degeneration

Yanbing Gao,
Xiyue Chen,
Guan Zheng
et al.

Abstract: Intervertebral disk (IVD) degeneration (IVDD) is a main factor in lower back pain, and immunomodulation plays a vital role in disease progression. The IVD is an immune privileged organ, and immunosuppressive molecules in tissues reduce immune cell (mainly monocytes/macrophages and mast cells) infiltration, and these cells can release proinflammatory cytokines and chemokines, disrupting the IVD microenvironment and leading to disease progression. Improving the inflammatory microenvironment in the IVD through im… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 148 publications
(159 reference statements)
0
1
0
Order By: Relevance
“…Developing a more effective model to induce IDD would hasten the currently prolonged periods of time required for IDD progression, thereby reducing model time and costs. Furthermore, identifying and suppressing this immune response could also be used to decrease the development and progression of IDD in patients affected by the condition ( 31 , 42 , 43 ).…”
Section: Discussionmentioning
confidence: 99%
“…Developing a more effective model to induce IDD would hasten the currently prolonged periods of time required for IDD progression, thereby reducing model time and costs. Furthermore, identifying and suppressing this immune response could also be used to decrease the development and progression of IDD in patients affected by the condition ( 31 , 42 , 43 ).…”
Section: Discussionmentioning
confidence: 99%